CERULOPLASMIN - ANVISA Registration 81692610214

Access comprehensive regulatory information for CERULOPLASMIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81692610214 and manufactured by VYTTRA DIAGNOSTICOS S.A.. The registration is held by VYTTRA DIAGNOSTICOS S.A. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, SENTINEL CH. SPA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.